ISSN: 1048-891X

International Journal of Gynecological Cancer Q1 Unclaimed

BMJ Publishing Group United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

International Journal of Gynecological Cancer, the official journal of ESGO, is the primary educational and informational publication for topics relevant to detection, prevention, diagnosis, and treatment of gynecologic malignancies. The journal is published nine times a year and offers great value to the medical field and to gynecologic oncologists around the world. It provides the latest research in the area of women’s cancer and offers a number of opportunities to learn not only the latest r It has an SJR impact factor of 1,134.

International Journal of Gynecological Cancer focuses its scope in these topics and keywords: cancer, cervical, endometrial, patients, radiation, ovarian, women, advanced, care, gene, ...

Type: Journal

Type of Copyright: CC BY

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: 9

Categories: Obstetrics and Gynecology (Q1) Oncology (Q2)

Price

2800 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

1,134

SJR Impact factor

95

H Index

329

Total Docs (Last Year)

965

Total Docs (3 years)

6992

Total Refs

3118

Total Cites (3 years)

733

Citable Docs (3 years)

3.02

Cites/Doc (2 years)

21.25

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Human Reproduction Update Q1
American Journal of Obstetrics and Gynecology Q1
Ultrasound in Obstetrics and Gynecology Q1
Obstetrics and Gynecology Q1
BJOG: An International Journal of Obstetrics and Gynaecology Q1

Compare this journals

Aims and Scope

Best articles by citations

Interval cervical cancer following treatment for cervical intraepithelial neoplasia

Parametrial involvement as a risk factor

p53 Polymorphism (codon-72) has no correlation with the development and the clinical features of cervical cancer

Parametrial spread in patients with endometrial carcinoma undergoing radical hysterectomy

Gastrointestinal stromal tumor arising in the rectovaginal septum

Aggressive endometriosis: report of a case

Are Muslim women less susceptible to oncogenic human papillomavirus infection? A study from rural eastern India

Topotecan in heavily pretreated patients with recurrent ovarian, peritoneal, and fallopian tube carcinoma

Venous Thromboembolism in Advanced Ovarian Cancer Patients Undergoing Frontline Adjuvant Chemotherapy

Prognostic factors in young women with endometrial carcinoma: a report of 20 cases and review of literature

Cyfra 21-1 marker in carcinoma of the cervix

Malignancies Diagnosed During Pregnancy and Treated With Chemotherapy or Other Modalities (Review of 27 Cases): Multicenter Experiences

SHOW MORE ARTICLES

Anti-cancer effect of adenovirus p53 on human cervical cancer cell growth in vitro and in vivo

Restoration of tumor specific human leukocyte antigens class I-restricted cytotoxicity by dendritic cell stimulation of tumor infiltrating lymphocytes in patients with advanced ovarian cancer

A case of peripheral primitive neuroectodermal tumor of the ovary

Primary peritoneal serous papillary carcinoma: A new epidemiologic trend? A matched-case comparison with ovarian serous papillary cancer

The growth factor receptors HER-2/neu and EGFR, their relationship, and their effects on the prognosis in early stage (FIGO I-II) epithelial ovarian carcinoma

Brain metastases from epithelial ovarian carcinoma

A retrospective comparison of current and proposed staging and scoring systems for persistent gestational trophoblastic disease

Multiple, disseminated cutaneous metastases of vulvar squamous cell carcinoma

Postoperative concurrent chronomodulated 5-fluorouracil/leucovorin infusion and pelvic radiotherapy for squamous cell carcinoma of the ovary arising from mature cystic teratoma

A pharmacokinetic and clinical evaluation of thio-TEPA in combination with cisplatin as first-line chemotherapy for advanced epithelial ovarian carcinoma

Letters to the Editor

A comparison of prognoses of FIGO stage IB adenocarcinoma and squamous cell carcinoma